Fights against dry skin conditions
A resilient skin barrier and equilibrium in the skin microbiome go hand in hand. Earlier studies have shown that our unique peptide derivative SYN-UP® can improve skin barrier function by rebalancing urokinase and plasmin levels in the epidermis. Now, a new clinical study shows that SYN-UP® also has excellent capacity to fight against dry skin conditions and, skin redness, due to its interaction on two common bacteria on the skin.
Staphylococcus Epidermidis is a keystone bacterium for the skin. It has anti-inflammatory properties and most strains play a role in maintaining skin health.
Corynebacterium Kroppenstedtii is also part of the normal skin microbiota, but increased levels have been associated with skin redness.
By influencing Staphylococcus Epidermidis and Corynebacterium Kroppenstedtii levels in the skin microbiome and rebalancing urokinase and plasmin symbiotically, SYN-UP™ fights against dry skin conditions and redness. This means consumers can have confidence in achieving a healthy-looking, skin.